Designed semisynthetic protein inhibitors of Ub/Ubl E1 activating enzymes.

Semisynthetic, mechanism-based protein inhibitors of ubiquitin (Ub) and ubiquitin-like modifier (Ubl) activating enzymes (E1s) have been developed to target E1-catalyzed adenylation and thioesterification of the Ub/Ubl C-terminus during the processes of protein SUMOylation and ubiquitination. The inhibitors were generated by intein-mediated expressed protein ligation using a truncated Ub/Ubl protein (SUMO residues 1-94; Ub residues 1-71) with a C-terminal thioester and synthetic tripeptides having a C-terminal adenosine analogue and an N-terminal cysteine residue. SUMO-AMSN (4a) and Ub-AMSN (4b) contain a sulfamide group as a nonhydrolyzable mimic of the phosphate group in the cognate Ub/Ubl-AMP adenylate intermediate in the first half-reaction, and these constructs selectively inhibit SUMO E1 and Ub E1, respectively, in a dose-dependent manner. SUMO-AVSN (5a) and Ub-AVSN (5b) contain an electrophilic vinyl sulfonamide designed to trap the incoming E1 cysteine nucleophile (Uba2 Cys173 in SUMO E1; Uba1 Cys593 in Ub E1) in the second half-reaction, and these constructs selectively, covalently, and stably cross-link to SUMO E1 and Ub E1, respectively, in a cysteine nucleophile-dependent manner. These inhibitors are powerful tools to probe outstanding mechanistic questions in E1 function and can also be used to study the biological functions of E1 enzymes.

[1]  Derek S. Tan,et al.  Small molecule inhibition of microbial natural product biosynthesis-an emerging antibiotic strategy. , 2008, Chemical Society reviews.

[2]  H. Schindelin,et al.  Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB–MoaD complex , 2001, Nature.

[3]  M. Burkart,et al.  Mechanism-based protein cross-linking probes to investigate carrier protein-mediated biosynthesis. , 2006, ACS chemical biology.

[4]  C. Lima,et al.  Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1 , 2005, The EMBO journal.

[5]  M. Marahiel,et al.  Aminoacyl Adenylate Substrate Analogues for the Inhibition of Adenylation Domains of Nonribosomal Peptide Synthetases , 2003, Chembiochem : a European journal of chemical biology.

[6]  M. Marahiel,et al.  Crystal structure of DhbE, an archetype for aryl acid activating domains of modular nonribosomal peptide synthetases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Adrian Saldanha,et al.  Structural basis for the spectral difference in luciferase bioluminescence , 2006, Nature.

[8]  Maria M. M. Santos,et al.  Michael acceptors as cysteine protease inhibitors. , 2007, Mini reviews in medicinal chemistry.

[9]  A. Mesecar,et al.  Bacillus anthracis o-succinylbenzoyl-CoA synthetase: reaction kinetics and a novel inhibitor mimicking its reaction intermediate. , 2008, Biochemistry.

[10]  M. Marahiel,et al.  Inhibition of the D‐alanine:D‐alanyl carrier protein ligase from Bacillus subtilis increases the bacterium's susceptibility to antibiotics that target the cell wall , 2005, The FEBS journal.

[11]  Amanda Doucette,et al.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer , 2009, Nature.

[12]  Yu Luo,et al.  Crystal structure and enantiomer selection by D-alanyl carrier protein ligase DltA from Bacillus cereus. , 2008, Biochemistry.

[13]  David W. Miller,et al.  The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. , 2003, Molecular cell.

[14]  R. Roeder,et al.  HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. , 2000, Molecular cell.

[15]  Tetsuya Hori,et al.  Structural Basis of the Substrate-specific Two-step Catalysis of Long Chain Fatty Acyl-CoA Synthetase Dimer* , 2004, Journal of Biological Chemistry.

[16]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[17]  S. Hubbard,et al.  Mechanism-based design of a protein kinase inhibitor , 2001, Nature Structural Biology.

[18]  M. Marahiel,et al.  Inhibition of aryl acid adenylation domains involved in bacterial siderophore synthesis , 2006, The FEBS journal.

[19]  B. Dye,et al.  Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins. , 2007, Annual review of biophysics and biomolecular structure.

[20]  Erica S. Johnson,et al.  Protein modification by SUMO. , 2004, Annual review of biochemistry.

[21]  Priyanka Verma,et al.  Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis , 2009, Nature chemical biology.

[22]  R. Wu,et al.  Structural characterization of a 140 degrees domain movement in the two-step reaction catalyzed by 4-chlorobenzoate:CoA ligase. , 2008, Biochemistry.

[23]  C. Lima,et al.  Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways. , 2007, Current opinion in structural biology.

[24]  Hermann Schindelin,et al.  Structural Insights into E1-Catalyzed Ubiquitin Activation and Transfer to Conjugating Enzymes , 2008, Cell.

[25]  P. Brick,et al.  Structure of tyrosyl-tRNA synthetase refined at 2.3 A resolution. Interaction of the enzyme with the tyrosyl adenylate intermediate. , 1989, Journal of molecular biology.

[26]  P. Cole,et al.  A mechanism-based inactivator for histone demethylase LSD1. , 2006, Journal of the American Chemical Society.

[27]  T. Muir.  Semisynthesis of proteins by expressed protein ligation. , 2003, Annual review of biochemistry.

[28]  Derek S. Tan,et al.  Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis , 2005, Nature chemical biology.

[29]  H. Ploegh,et al.  Specific and Covalent Targeting of Conjugating and Deconjugating Enzymes of Ubiquitin-Like Proteins , 2004, Molecular and Cellular Biology.

[30]  C. Aldrich,et al.  Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis. , 2006, Journal of medicinal chemistry.

[31]  W. Roush,et al.  Relative rates of Michael reactions of 2'-(phenethyl)thiol with vinyl sulfones, vinyl sulfonate esters, and vinyl sulfonamides relevant to vinyl sulfonyl cysteine protease inhibitors. , 2003, Organic letters.

[32]  Derek S. Tan,et al.  Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis. , 2008, Bioorganic & medicinal chemistry letters.

[33]  Courtney C Aldrich,et al.  A mechanism-based aryl carrier protein/thiolation domain affinity probe. , 2007, Journal of the American Chemical Society.

[34]  H. Ueda,et al.  X-ray crystallographic conformational study of 5'-O-[N-(L-alanyl)-sulfamoyl]adenosine, a substrate analogue for alanyl-tRNA synthetase. , 1991, Biochimica et biophysica acta.